We like to inform you that Board Meeting of the Company was held today i.e. on Thursday, May 09, 2018 at 4.00 P.M., at 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400072. The Board has considered and approved in pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 the following: 1. The unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2018; 2. Limited Review Report on the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2018; 3. Resignation of Mrs. Sushama Yadav as Company Secretary & Compliance officer w.e.f. August 09, 2018; 4. Appointed of Ms. Aditi Bhatt as Company Secretary & Compliance officer w.e.f. August 09, 2018. Kindly take the same on record.

Pdf Link: Bliss Gvs Pharma Ltd. - Submission Of Standalone & Consolidated Unaudited Financial Results Alongwith Limited Review Report For The Quarter Ended June 30, 2018

Source : BSE - www.bseindia.com